iodine has been researched along with Lymph Node Metastasis in 58 studies
Iodine: A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically.
diiodine : Molecule comprising two covalently bonded iodine atoms with overall zero charge..
Excerpt | Relevance | Reference |
---|---|---|
"We aimed to investigate the association between iodine intake and nodal metastasis stratified by central lymph node metastasis (CLNM) and lateral lymph node metastasis (LLNM) of papillary thyroid microcarcinoma (PTMC)." | 8.31 | Association between iodine nutrition and cervical lymph node metastasis of papillary thyroid microcarcinoma. ( Cui, L; Gong, Y; Hu, J; Huang, T; Zhao, H, 2023) |
"To develop and validate 2 iodine maps based radiomics nomograms for preoperatively predicting cervical lymph node metastasis (LNM) and central lymph node metastasis (CLNM) in papillary thyroid cancer (PTC)." | 8.12 | Radiomics from Primary Tumor on Dual-Energy CT Derived Iodine Maps can Predict Cervical Lymph Node Metastasis in Papillary Thyroid Cancer. ( Ge, YQ; Hu, H; Shen, MP; Si, Y; Su, GY; Tao, XW; Wu, FY; Xu, XQ; Zhou, Y, 2022) |
"The aim of this study was to retrospectively identify the effect of iodine on the papillary thyroid cancer (PTC) process and investigate the risk clinicopathologic characteristics of cervical lymph node metastasis (CLNM) for achieving a better preventive strategy of PTC." | 8.02 | High Iodine Nutrition May Be a Risk Factor for Cervical Lymph Node Metastasis in Papillary Thyroid Cancer Patients. ( Fan, L; Guo, L; He, Q; Miao, S; Sun, D; Sun, J; Sun, Q; Tian, Q; Wang, F; Xiu, C; Yang, X; Yuan, Z, 2021) |
"To investigate the value of dual-energy computed tomography (DECT)-derived iodine and fat quantification in differentiating malignant abdominal lymphoma from lymph node metastasis." | 7.88 | Dual-energy CT-based iodine quantification to differentiate abdominal malignant lymphoma from lymph node metastasis. ( Albrecht, MH; Arendt, C; Czwikla, R; Hammerstingl, R; Kaltenbach, B; Lenga, L; Martin, SS; Savage, RH; Vogl, TJ; Wichmann, JL, 2018) |
"Patients with breast cancer clinical tumor categories 1 through 4 (cT1-4; tumor diameter <2 cm and up to >5 cm or extension to the chest wall or skin) and pathologically proven positive axillary lymph nodes (ie, clinical node categories cN1, metastases to movable ipsilateral level I and/or level II axillary nodes; cN2, metastases to fixed or matted ipsilateral level I and/or level II axillary nodes; cN3b, metastases to ipsilateral level I and/or level II axillary nodes with metastases to internal mammary nodes) who were treated with NAC were eligible for inclusion." | 5.72 | Diagnostic Accuracy of Radioactive Iodine Seed Placement in the Axilla With Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer. ( Boskamp, M; Contant, CME; de Boer, M; Heijmans, HJ; Jager, A; Kam, BLR; Kelder, W; Koppert, LB; Lobbes, MBI; Luiten, EJT; Menke-Pluijmers, MBE; Sars, PRA; Simons, JM; Smidt, ML; Smit, LHM; van der Pol, CC; van Diest, PJ; van Haaren, ERM; van Klaveren, D; van Nijnatten, TJA; Verhoef, C; Vles, WJ, 2022) |
"Low iodine was a protective factor for CLNM in papillary thyroid cancer, particularly in those < 1 cm." | 5.62 | Low urinary iodine is a protective factor of central lymph node metastasis in papillary thyroid cancer: a cross-sectional study. ( Kang, W; Li, K; Liu, Z; Ouyang, S; Sun, J; Wang, X; Ye, X; Yu, J; Zeng, Z; Zhang, Z, 2021) |
"We aimed to investigate the association between iodine intake and nodal metastasis stratified by central lymph node metastasis (CLNM) and lateral lymph node metastasis (LLNM) of papillary thyroid microcarcinoma (PTMC)." | 4.31 | Association between iodine nutrition and cervical lymph node metastasis of papillary thyroid microcarcinoma. ( Cui, L; Gong, Y; Hu, J; Huang, T; Zhao, H, 2023) |
"To develop and validate 2 iodine maps based radiomics nomograms for preoperatively predicting cervical lymph node metastasis (LNM) and central lymph node metastasis (CLNM) in papillary thyroid cancer (PTC)." | 4.12 | Radiomics from Primary Tumor on Dual-Energy CT Derived Iodine Maps can Predict Cervical Lymph Node Metastasis in Papillary Thyroid Cancer. ( Ge, YQ; Hu, H; Shen, MP; Si, Y; Su, GY; Tao, XW; Wu, FY; Xu, XQ; Zhou, Y, 2022) |
"The aim of this study was to retrospectively identify the effect of iodine on the papillary thyroid cancer (PTC) process and investigate the risk clinicopathologic characteristics of cervical lymph node metastasis (CLNM) for achieving a better preventive strategy of PTC." | 4.02 | High Iodine Nutrition May Be a Risk Factor for Cervical Lymph Node Metastasis in Papillary Thyroid Cancer Patients. ( Fan, L; Guo, L; He, Q; Miao, S; Sun, D; Sun, J; Sun, Q; Tian, Q; Wang, F; Xiu, C; Yang, X; Yuan, Z, 2021) |
"To investigate the value of dual-energy computed tomography (DECT)-derived iodine and fat quantification in differentiating malignant abdominal lymphoma from lymph node metastasis." | 3.88 | Dual-energy CT-based iodine quantification to differentiate abdominal malignant lymphoma from lymph node metastasis. ( Albrecht, MH; Arendt, C; Czwikla, R; Hammerstingl, R; Kaltenbach, B; Lenga, L; Martin, SS; Savage, RH; Vogl, TJ; Wichmann, JL, 2018) |
"Follicular thyroid carcinoma (FTC) and Hurthle cell carcinoma (HCC) of the thyroid are relatively uncommon thyroid malignancies in iodine-sufficient areas." | 3.80 | Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter data. ( Cho, BY; Chung, JH; Jang, HW; Jo, YS; Kim, SW; Kim, TH; Kim, TY; Kim, WB; Kim, WG; Park, DJ; Park, YJ; Shong, M; Shong, YK, 2014) |
"These data suggest that the potential malignancy of thyroid nodules is not only correlated to the diameter but to other parameters such as the biological difference of thyroid cancer that could be hypothesized in an iodine deficiency area." | 3.71 | [Prevalence and aggressiveness of thyroid carcinoma with diameter less than one centimetre in iodine deficiency areas]. ( Agosti, B; Cappelli, C; Cerudelli, B; Cumetti, D; Morassi, ML; Pelizzari, G; Tironi, A, 2002) |
"TSH stimulation of adenylate cyclase (AC) and iodine uptake was compared in 39 surgical specimens of primary tumours and/or lymph node metastases from 29 human differentiated thyroid carcinomas." | 3.66 | Thyrotrophin stimulation of adenylate cyclase and iodine uptake in human differentiated thyroid cancer. ( Carayon, P; Schlumberger, M; Thomas-Morvan, C; Tubiana, M; Vignal, A, 1982) |
"The effect of iodine on papillary thyroid cancer (PTC) has been controversial for many years." | 2.82 | The relationship between urinary iodine concentration and papillary thyroid cancer: A systematic review and meta-analysis. ( Aihaiti, R; Chen, D; Feng, C; Li, Q; Teng, W; Zhang, F; Zhang, X; Zhao, X, 2022) |
"Iodine avidity was prospectively assessed pre-therapeutically in 35 patients by injection of tracer amounts of iodine-131 two days prior to surgery." | 1.91 | Primary tumour iodine avidity in relation to uptake in persistent metastatic disease in papillary and poorly differentiated thyroid cancer. ( Grybäck, P; Hedman, C; Juhlin, CC; Lundgren, CI; Nilsson, JN, 2023) |
"Patients with breast cancer clinical tumor categories 1 through 4 (cT1-4; tumor diameter <2 cm and up to >5 cm or extension to the chest wall or skin) and pathologically proven positive axillary lymph nodes (ie, clinical node categories cN1, metastases to movable ipsilateral level I and/or level II axillary nodes; cN2, metastases to fixed or matted ipsilateral level I and/or level II axillary nodes; cN3b, metastases to ipsilateral level I and/or level II axillary nodes with metastases to internal mammary nodes) who were treated with NAC were eligible for inclusion." | 1.72 | Diagnostic Accuracy of Radioactive Iodine Seed Placement in the Axilla With Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer. ( Boskamp, M; Contant, CME; de Boer, M; Heijmans, HJ; Jager, A; Kam, BLR; Kelder, W; Koppert, LB; Lobbes, MBI; Luiten, EJT; Menke-Pluijmers, MBE; Sars, PRA; Simons, JM; Smidt, ML; Smit, LHM; van der Pol, CC; van Diest, PJ; van Haaren, ERM; van Klaveren, D; van Nijnatten, TJA; Verhoef, C; Vles, WJ, 2022) |
"Low iodine was a protective factor for CLNM in papillary thyroid cancer, particularly in those < 1 cm." | 1.62 | Low urinary iodine is a protective factor of central lymph node metastasis in papillary thyroid cancer: a cross-sectional study. ( Kang, W; Li, K; Liu, Z; Ouyang, S; Sun, J; Wang, X; Ye, X; Yu, J; Zeng, Z; Zhang, Z, 2021) |
"Background Anaplastic thyroid cancer (ATC) is one of the most aggressive tumors." | 1.56 | Dietary iodine intake, therapy with radioiodine, and anaplastic thyroid carcinoma. ( Besic, N; Gazic, B, 2020) |
"Iodine overlay (HU) was also significantly lower for metastatic lymph nodes (47 ± 11." | 1.40 | Comparison of dual-energy CT-derived iodine content and iodine overlay of normal, inflammatory and metastatic squamous cell carcinoma cervical lymph nodes. ( Bauer, R; Kerl, JM; Nour-Eldin, NE; Razek, AA; Tawfik, AM; Vogl, TJ, 2014) |
"A PTMC was defined as a papillary thyroid carcinoma with a diameter ≤ 10 mm." | 1.38 | Papillary thyroid microcarcinoma: clinicopathological characteristics and implications for treatment in 276 patients. ( Charitoudis, G; Kapetanakis, S; Karakostas, E; Karatzas, T; Kouraklis, G; Stavrianaki, A; Vasileiadis, I, 2012) |
"Amiodarone has a high iodine content that can induce persistent iodine excess and may prevent radioiodine (RI) treatment." | 1.35 | Plasma exchanges overcome persistent iodine overload to enable 131I ablation of differentiated thyroid carcinoma. ( Dib-Deperrest, A; Hindie, E; Houzé, P; Moretti, JL; Parquet, N; Toubert, ME, 2008) |
"Lymph node metastases as well as the age of patients were not found to be independent prognostic factors." | 1.33 | Is patient's age a prognostic factor for follicular thyroid carcinoma in the TNM classification system? ( Besic, N; Frkovic-Grazio, S; Hocevar, M; Zgajnar, J, 2005) |
"Histologically, the resected pituitary adenoma was a TSH-producing adenoma (TSH-oma) and the thyroid nodule was a papillary adenocarcinoma." | 1.31 | Hyperthyroidism in a patient with TSH-producing pituitary adenoma coexisting with thyroid papillary adenocarcinoma. ( Doihara, H; Kataoka, H; Kishida, M; Makino, H; Mimura, Y; Ogura, T; Oishi, T; Otsuka, F; Tamiya, T; Yamauchi, T; Yokota, K, 2000) |
"Initial symptoms of thyroid cancer were collected and analysed for 1116 patients with thyroid cancer in an iodine-deficient region, retrospectively for the period 1960-80 (604 patients), prospectively for 1981-87 (512)." | 1.28 | [Initial symptoms of malignant thyroid tumors: the effect of age and sex in an iodine-deficient region. Experiences with 1116 patients]. ( Benker, G; Creutzig, H; Eigler, FW; Leder, LD; Mlynek, ML; Reiners, C; Reinwein, D; Windeck, R, 1989) |
"Modes of treatment for cervical cancer will vary according to geographic location, the expertise of those providing treatment, and current clinical trials." | 1.26 | Is the cervix normal? How do you arrive at that conclusion? ( Fraser, RC, 1976) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (13.79) | 18.7374 |
1990's | 5 (8.62) | 18.2507 |
2000's | 11 (18.97) | 29.6817 |
2010's | 16 (27.59) | 24.3611 |
2020's | 18 (31.03) | 2.80 |
Authors | Studies |
---|---|
Liu, Y | 1 |
Nie, Y | 1 |
Zou, Y | 1 |
Shi, Y | 1 |
Sun, F | 1 |
Liu, J | 5 |
Guo, Y | 1 |
Zhang, H | 1 |
Lu, X | 1 |
Gong, Y | 2 |
Xia, S | 1 |
Chen, WB | 1 |
Shi, QQ | 1 |
Li, ZM | 1 |
Li, ZY | 1 |
Kang, LQ | 1 |
Simons, JM | 1 |
van Nijnatten, TJA | 1 |
van der Pol, CC | 1 |
van Diest, PJ | 1 |
Jager, A | 1 |
van Klaveren, D | 1 |
Kam, BLR | 1 |
Lobbes, MBI | 1 |
de Boer, M | 1 |
Verhoef, C | 1 |
Sars, PRA | 1 |
Heijmans, HJ | 1 |
van Haaren, ERM | 1 |
Vles, WJ | 1 |
Contant, CME | 1 |
Menke-Pluijmers, MBE | 1 |
Smit, LHM | 1 |
Kelder, W | 1 |
Boskamp, M | 1 |
Koppert, LB | 1 |
Luiten, EJT | 1 |
Smidt, ML | 1 |
Luo, YH | 1 |
Mei, XL | 1 |
Liu, QR | 1 |
Jiang, B | 1 |
Zhang, S | 1 |
Zhang, K | 1 |
Wu, X | 1 |
Luo, YM | 1 |
Li, YJ | 1 |
Zhao, M | 1 |
Shi, X | 1 |
Zhang, J | 1 |
Deng, S | 1 |
Zhou, Y | 3 |
Wen, R | 1 |
Lu, Y | 1 |
Zhang, B | 1 |
Zhang, X | 3 |
Zhang, F | 4 |
Li, Q | 3 |
Aihaiti, R | 3 |
Feng, C | 3 |
Chen, D | 3 |
Zhao, X | 3 |
Teng, W | 3 |
Xu, S | 3 |
Huang, H | 3 |
Huang, Y | 3 |
Qian, J | 3 |
Wang, X | 5 |
Xu, Z | 3 |
Liu, S | 3 |
Pan, H | 1 |
Lin, Q | 1 |
Chen, X | 1 |
Huang, Z | 1 |
Huang, X | 1 |
Tang, L | 1 |
Nilsson, JN | 2 |
Grybäck, P | 1 |
Juhlin, CC | 2 |
Hedman, C | 2 |
Lundgren, CI | 1 |
Siikanen, J | 1 |
Condello, V | 1 |
Jatta, K | 1 |
Saini, R | 1 |
Ihre Lundgren, C | 1 |
Munck, F | 1 |
Jepsen, P | 1 |
Zeuthen, P | 1 |
Carstensen, L | 1 |
Hauerslev, K | 1 |
Paaskesen, CK | 1 |
Andersen, IS | 1 |
Høyer, U | 1 |
Lanng, C | 1 |
Gerlach, MK | 1 |
Vejborg, I | 1 |
Kroman, NT | 1 |
Tvedskov, THF | 1 |
Zhao, H | 2 |
Hu, J | 1 |
Cui, L | 1 |
Huang, T | 2 |
Besic, N | 3 |
Gazic, B | 1 |
Su, GY | 2 |
Hu, H | 2 |
Ge, YQ | 2 |
Si, Y | 2 |
Shen, MP | 2 |
Xu, XQ | 2 |
Wu, FY | 2 |
Zeng, Z | 1 |
Li, K | 1 |
Ouyang, S | 1 |
Zhang, Z | 1 |
Liu, Z | 1 |
Sun, J | 2 |
Ye, X | 1 |
Kang, W | 1 |
Yu, J | 1 |
Fan, L | 1 |
Tian, Q | 1 |
Xiu, C | 1 |
Wang, F | 1 |
Yuan, Z | 1 |
He, Q | 1 |
Guo, L | 1 |
Sun, Q | 1 |
Yang, X | 1 |
Miao, S | 1 |
Sun, D | 1 |
Tao, XW | 1 |
Kim, H | 1 |
Jang, EJ | 1 |
Kyum Kim, S | 1 |
Jin Hyung, W | 1 |
Kyu Choi, D | 1 |
Lim, SJ | 1 |
Seok Lim, J | 1 |
Bogdanova, TI | 1 |
Saenko, VA | 1 |
Hirokawa, M | 1 |
Ito, M | 2 |
Zurnadzhy, LY | 1 |
Hayashi, T | 1 |
Rogounovitch, TI | 1 |
Miyauchi, A | 1 |
Tronko, MD | 1 |
Yamashita, S | 2 |
Rizzo, S | 1 |
Radice, D | 1 |
Femia, M | 1 |
De Marco, P | 1 |
Origgi, D | 1 |
Preda, L | 1 |
Barberis, M | 1 |
Vigorito, R | 1 |
Mauri, G | 1 |
Mauro, A | 1 |
Bellomi, M | 1 |
Martin, SS | 1 |
Czwikla, R | 1 |
Wichmann, JL | 1 |
Albrecht, MH | 1 |
Lenga, L | 1 |
Savage, RH | 1 |
Arendt, C | 1 |
Hammerstingl, R | 1 |
Vogl, TJ | 2 |
Kaltenbach, B | 1 |
Li, H | 1 |
Tawfik, AM | 1 |
Razek, AA | 1 |
Kerl, JM | 1 |
Nour-Eldin, NE | 1 |
Bauer, R | 1 |
Kim, WG | 1 |
Kim, TY | 1 |
Kim, TH | 1 |
Jang, HW | 1 |
Jo, YS | 1 |
Park, YJ | 1 |
Kim, SW | 1 |
Kim, WB | 1 |
Shong, M | 1 |
Park, DJ | 1 |
Chung, JH | 1 |
Shong, YK | 1 |
Cho, BY | 1 |
Bogdanova, T | 1 |
Zurnadzhy, L | 1 |
Saenko, V | 1 |
Rogounovitch, T | 1 |
Mitsutake, N | 1 |
Kondo, H | 1 |
Maeda, S | 1 |
Nakashima, M | 1 |
Tronko, M | 1 |
Kato, T | 1 |
Uehara, K | 1 |
Ishigaki, S | 1 |
Nihashi, T | 1 |
Arimoto, A | 1 |
Nakamura, H | 1 |
Kamiya, T | 1 |
Oshiro, T | 1 |
Ebata, T | 1 |
Nagino, M | 1 |
Baxa, J | 1 |
Matouskova, T | 1 |
Krakorova, G | 1 |
Schmidt, B | 1 |
Flohr, T | 1 |
Sedlmair, M | 1 |
Bejcek, J | 1 |
Ferda, J | 1 |
Li, X | 1 |
Meng, X | 1 |
Ye, Z | 1 |
Cong, BB | 1 |
Qiu, PF | 1 |
Liu, YB | 1 |
Zhao, T | 1 |
Chen, P | 1 |
Cao, XS | 1 |
Wang, CJ | 1 |
Zhang, ZP | 1 |
Sun, X | 1 |
Yu, JM | 1 |
Wang, YS | 1 |
Liu, B | 1 |
Li, Y | 1 |
Wang, Y | 1 |
Wang, W | 1 |
Wang, L | 1 |
Hertzanu, Y | 1 |
Wang, J | 1 |
Yang, F | 1 |
Dong, J | 1 |
Fu, X | 1 |
Zhang, T | 1 |
Schmid-Bindert, G | 1 |
Henzler, T | 1 |
Chu, TQ | 1 |
Meyer, M | 1 |
Nance, JW | 1 |
Schoepf, UJ | 1 |
Dinter, DJ | 1 |
Apfaltrer, P | 1 |
Krissak, R | 1 |
Manegold, C | 1 |
Schoenberg, SO | 1 |
Fink, C | 1 |
Vasileiadis, I | 1 |
Karakostas, E | 1 |
Charitoudis, G | 1 |
Stavrianaki, A | 1 |
Kapetanakis, S | 1 |
Kouraklis, G | 1 |
Karatzas, T | 1 |
Sarda, AK | 1 |
Kapur, MM | 1 |
Zgajnar, J | 2 |
Hocevar, M | 2 |
Frkovic-Grazio, S | 1 |
Petric, R | 1 |
Pilko, G | 1 |
Mishra, A | 1 |
Pal, L | 1 |
Mishra, SK | 1 |
Toubert, ME | 1 |
Dib-Deperrest, A | 1 |
Houzé, P | 1 |
Parquet, N | 1 |
Hindie, E | 1 |
Moretti, JL | 1 |
Tabei, T | 1 |
Tsukui, T | 1 |
Nomoto, C | 1 |
Suemasu, K | 1 |
Higashi, Y | 1 |
Thomas-Morvan, C | 1 |
Carayon, P | 1 |
Schlumberger, M | 2 |
Vignal, A | 1 |
Tubiana, M | 1 |
Ishikita, T | 1 |
Wisner, ER | 2 |
Katzberg, RW | 2 |
Griffey, SM | 2 |
Haley, PJ | 2 |
Johnson, DK | 1 |
Vessey, AR | 2 |
Link, DP | 1 |
Drake, CM | 1 |
Johnson, D | 1 |
Noguchi, M | 1 |
Katev, N | 1 |
Miwa, K | 1 |
Raman, A | 1 |
Nair, A | 1 |
Arturi, F | 1 |
Russo, D | 1 |
Giuffrida, D | 1 |
Filetti, S | 1 |
Kishida, M | 1 |
Otsuka, F | 1 |
Kataoka, H | 1 |
Yokota, K | 1 |
Oishi, T | 1 |
Yamauchi, T | 1 |
Doihara, H | 1 |
Tamiya, T | 1 |
Mimura, Y | 1 |
Ogura, T | 1 |
Makino, H | 1 |
Györy, F | 1 |
Lukács, G | 1 |
Nagy, EV | 1 |
Juhász, F | 1 |
Mezösi, E | 1 |
Szakáll, S | 1 |
Máth, J | 1 |
Balázs, G | 1 |
Bal, CS | 1 |
Padhy, AK | 1 |
Kumar, A | 1 |
Cappelli, C | 1 |
Agosti, B | 1 |
Tironi, A | 1 |
Morassi, ML | 1 |
Pelizzari, G | 1 |
Cumetti, D | 1 |
Cerudelli, B | 1 |
Fraser, RC | 1 |
Evered, DC | 1 |
Reinwein, D | 1 |
Benker, G | 1 |
Windeck, R | 1 |
Eigler, FW | 1 |
Leder, LD | 1 |
Mlynek, ML | 1 |
Creutzig, H | 1 |
Reiners, C | 1 |
Hirai, Y | 1 |
Kaku, S | 1 |
Teshima, H | 1 |
Chen, JT | 1 |
Hamada, T | 1 |
Fujimoto, I | 1 |
Yamauchi, K | 1 |
Mine, H | 1 |
Hasumi, K | 1 |
Masubuchi, K | 1 |
Irino, S | 1 |
Tanji, T | 1 |
Uno, J | 1 |
Oka, A | 1 |
Hill, LD | 1 |
Beebe, HG | 1 |
Hipp, R | 1 |
Jones, HW | 1 |
Beer, GM | 1 |
Baumüller, S | 1 |
Zech, N | 1 |
Wyss, P | 1 |
Strasser, D | 1 |
Varga, Z | 1 |
Seifert, B | 1 |
Hafner, J | 1 |
Mihic-Probst, D | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Optimized Response Assessment of Gastrointestinal Stromal Tumors Using Dual-Energy CT: Prospective Multicenter-Multinational Trial in Patients Undergoing Targeted Therapy With a TKI Inhibitor.[NCT03404076] | 93 participants (Actual) | Observational | 2014-12-01 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 reviews available for iodine and Lymph Node Metastasis
Article | Year |
---|---|
Radioactive Iodine Ablation Can Reduce the Structural Recurrence Rate of Intermediate-Risk Papillary Thyroid Microcarcinoma: A Meta-Analysis.
Topics: Carcinoma, Papillary; Humans; Iodine; Iodine Radioisotopes; Lymphatic Metastasis; Neoplasm Recurrenc | 2022 |
The relationship between urinary iodine concentration and papillary thyroid cancer: A systematic review and meta-analysis.
Topics: Humans; Iodine; Lymphatic Metastasis; Proto-Oncogene Proteins B-raf; Thyroid Cancer, Papillary; Thyr | 2022 |
The relationship between urinary iodine concentration and papillary thyroid cancer: A systematic review and meta-analysis.
Topics: Humans; Iodine; Lymphatic Metastasis; Proto-Oncogene Proteins B-raf; Thyroid Cancer, Papillary; Thyr | 2022 |
The relationship between urinary iodine concentration and papillary thyroid cancer: A systematic review and meta-analysis.
Topics: Humans; Iodine; Lymphatic Metastasis; Proto-Oncogene Proteins B-raf; Thyroid Cancer, Papillary; Thyr | 2022 |
The relationship between urinary iodine concentration and papillary thyroid cancer: A systematic review and meta-analysis.
Topics: Humans; Iodine; Lymphatic Metastasis; Proto-Oncogene Proteins B-raf; Thyroid Cancer, Papillary; Thyr | 2022 |
The relationship between urinary iodine concentration and papillary thyroid cancer: A systematic review and meta-analysis.
Topics: Humans; Iodine; Lymphatic Metastasis; Proto-Oncogene Proteins B-raf; Thyroid Cancer, Papillary; Thyr | 2022 |
The relationship between urinary iodine concentration and papillary thyroid cancer: A systematic review and meta-analysis.
Topics: Humans; Iodine; Lymphatic Metastasis; Proto-Oncogene Proteins B-raf; Thyroid Cancer, Papillary; Thyr | 2022 |
The relationship between urinary iodine concentration and papillary thyroid cancer: A systematic review and meta-analysis.
Topics: Humans; Iodine; Lymphatic Metastasis; Proto-Oncogene Proteins B-raf; Thyroid Cancer, Papillary; Thyr | 2022 |
The relationship between urinary iodine concentration and papillary thyroid cancer: A systematic review and meta-analysis.
Topics: Humans; Iodine; Lymphatic Metastasis; Proto-Oncogene Proteins B-raf; Thyroid Cancer, Papillary; Thyr | 2022 |
The relationship between urinary iodine concentration and papillary thyroid cancer: A systematic review and meta-analysis.
Topics: Humans; Iodine; Lymphatic Metastasis; Proto-Oncogene Proteins B-raf; Thyroid Cancer, Papillary; Thyr | 2022 |
Therapeutic strategies and long-term results in differentiated thyroid cancer.
Topics: Combined Modality Therapy; Humans; Iodine; Lymph Node Excision; Lymphatic Metastasis; Neoplasm Recur | 1998 |
1 trial available for iodine and Lymph Node Metastasis
Article | Year |
---|---|
Sodium-iodide symporter (NIS) gene expression in lymph-node metastases of papillary thyroid carcinomas.
Topics: Adolescent; Adult; Aged; Carcinoma, Papillary; Carrier Proteins; Electrophoresis, Agar Gel; Female; | 2000 |
54 other studies available for iodine and Lymph Node Metastasis
Article | Year |
---|---|
Correlation with Spectral CT Imaging Parameters and Occult Lymph Nodes Metastases in Sufferers with Isolated Lung Adenocarcinoma.
Topics: Adenocarcinoma of Lung; Humans; Iodine; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Tomograph | 2022 |
Extreme gradient boosting model to assess risk of central cervical lymph node metastasis in patients with papillary thyroid carcinoma: Individual prediction using SHapley Additive exPlanations.
Topics: Humans; Iodine; Lymph Nodes; Lymphatic Metastasis; Reproducibility of Results; Retrospective Studies | 2022 |
Diagnostic value of spiral CT energy spectrum imaging in lymph node metastasis of colorectal cancer.
Topics: Colorectal Neoplasms; Humans; Iodine; Lymph Nodes; Lymphatic Metastasis; Retrospective Studies; Tomo | 2022 |
Diagnostic Accuracy of Radioactive Iodine Seed Placement in the Axilla With Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer.
Topics: Axilla; Breast Neoplasms; Female; Humans; Iodine; Iodine Radioisotopes; Lymph Node Excision; Lymph N | 2022 |
Diagnosing cervical lymph node metastasis in oral squamous cell carcinoma based on third-generation dual-source, dual-energy computed tomography.
Topics: Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Iodine; Lymph Nodes; Lymphatic Metastasis | 2023 |
Comparison of Lobectomy vs Total Thyroidectomy for Intermediate-Risk Papillary Thyroid Carcinoma With Lymph Node Metastasis.
Topics: Adult; Carcinoma, Papillary; Cohort Studies; Female; Humans; Iodine; Iodine Radioisotopes; Lymph Nod | 2023 |
Comparison of Lobectomy vs Total Thyroidectomy for Intermediate-Risk Papillary Thyroid Carcinoma With Lymph Node Metastasis.
Topics: Adult; Carcinoma, Papillary; Cohort Studies; Female; Humans; Iodine; Iodine Radioisotopes; Lymph Nod | 2023 |
Comparison of Lobectomy vs Total Thyroidectomy for Intermediate-Risk Papillary Thyroid Carcinoma With Lymph Node Metastasis.
Topics: Adult; Carcinoma, Papillary; Cohort Studies; Female; Humans; Iodine; Iodine Radioisotopes; Lymph Nod | 2023 |
Comparison of Lobectomy vs Total Thyroidectomy for Intermediate-Risk Papillary Thyroid Carcinoma With Lymph Node Metastasis.
Topics: Adult; Carcinoma, Papillary; Cohort Studies; Female; Humans; Iodine; Iodine Radioisotopes; Lymph Nod | 2023 |
Added value of spectral parameters in diagnosing metastatic lymph nodes of pT1-2 rectal cancer.
Topics: Humans; Iodine; Lymph Nodes; Lymphatic Metastasis; Rectal Neoplasms; Retrospective Studies; ROC Curv | 2023 |
Primary tumour iodine avidity in relation to uptake in persistent metastatic disease in papillary and poorly differentiated thyroid cancer.
Topics: Adenocarcinoma; Humans; Iodine; Iodine Radioisotopes; Lymphatic Metastasis; Retrospective Studies; T | 2023 |
Iodine avidity in papillary and poorly differentiated thyroid cancer is predicted by immunohistochemical and molecular work-up.
Topics: Adenocarcinoma; Carcinoma, Papillary; Humans; Iodine; Iodine Radioisotopes; Lymphatic Metastasis; Pr | 2023 |
Comparing Methods for Targeted Axillary Dissection in Breast Cancer Patients: A Nationwide, Retrospective Study.
Topics: Axilla; Breast Neoplasms; Female; Humans; Iodine; Lymph Node Excision; Lymph Nodes; Lymphadenopathy; | 2023 |
Association between iodine nutrition and cervical lymph node metastasis of papillary thyroid microcarcinoma.
Topics: Female; Humans; Iodine; Lymphatic Metastasis; Male; Neck; Thyroid Neoplasms | 2023 |
Dietary iodine intake, therapy with radioiodine, and anaplastic thyroid carcinoma.
Topics: Aged; Female; Humans; Incidence; Iodine; Iodine Radioisotopes; Lymphatic Metastasis; Male; Potassium | 2020 |
Radiomics analysis of dual-energy CT-derived iodine maps for diagnosing metastatic cervical lymph nodes in patients with papillary thyroid cancer.
Topics: Adolescent; Adult; Aged; Algorithms; Decision Support Techniques; Female; Humans; Image Processing, | 2020 |
Low urinary iodine is a protective factor of central lymph node metastasis in papillary thyroid cancer: a cross-sectional study.
Topics: Cross-Sectional Studies; Humans; Iodine; Lymph Nodes; Lymphatic Metastasis; Prognosis; Protective Fa | 2021 |
High Iodine Nutrition May Be a Risk Factor for Cervical Lymph Node Metastasis in Papillary Thyroid Cancer Patients.
Topics: Adult; Female; Humans; Iodine; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Retrospective S | 2021 |
Radiomics from Primary Tumor on Dual-Energy CT Derived Iodine Maps can Predict Cervical Lymph Node Metastasis in Papillary Thyroid Cancer.
Topics: Humans; Iodine; Lymph Nodes; Lymphatic Metastasis; Nomograms; Retrospective Studies; Thyroid Cancer, | 2022 |
Simultaneous sentinel lymph node computed tomography and locoregional chemotherapy for lymph node metastasis in rabbit using an iodine-docetaxel emulsion.
Topics: Animals; Disease Models, Animal; Docetaxel; Drug Stability; Emulsions; Iodine; Lymphatic Metastasis; | 2017 |
Comparative histopathological analysis of sporadic pediatric papillary thyroid carcinoma from Japan and Ukraine.
Topics: Adolescent; Adolescent Development; Age Factors; Carcinoma, Papillary; Child; Child, Preschool; Diet | 2017 |
Metastatic and non-metastatic lymph nodes: quantification and different distribution of iodine uptake assessed by dual-energy CT.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Female; Humans; Iodine; Ioh | 2018 |
Dual-energy CT-based iodine quantification to differentiate abdominal malignant lymphoma from lymph node metastasis.
Topics: Abdomen; Adult; Aged; Diagnosis, Differential; Female; Humans; Iodine; Lymph Nodes; Lymphatic Metast | 2018 |
High iodine intake and central lymph node metastasis risk of papillary thyroid cancer.
Topics: Disease Progression; Female; Humans; Iodine; Lymphatic Metastasis; Male; Middle Aged; Multivariate A | 2019 |
Comparison of dual-energy CT-derived iodine content and iodine overlay of normal, inflammatory and metastatic squamous cell carcinoma cervical lymph nodes.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; I | 2014 |
Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter data.
Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Adult; Age Factors; Diet; Female; Humans; Iodine; Ly | 2014 |
Morphological difference in adult thyroid papillary carcinoma between Japan and Ukraine.
Topics: Adult; Carcinoma; Carcinoma, Papillary; Carcinoma, Papillary, Follicular; Cell Proliferation; Cherno | 2014 |
Clinical significance of dual-energy CT-derived iodine quantification in the diagnosis of metastatic LN in colorectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Colorectal Neoplasms; Female; Humans; Iodine; Lymph Nodes; Lymphatic Me | 2015 |
Dual-Phase Dual-Energy CT in Patients Treated with Erlotinib for Advanced Non-Small Cell Lung Cancer: Possible Benefits of Iodine Quantification in Response Assessment.
Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Female; Humans | 2016 |
Iodine quantification to characterize primary lesions, metastatic and non-metastatic lymph nodes in lung cancers by dual energy computed tomography: An initial experience.
Topics: Carcinoma, Non-Small-Cell Lung; Contrast Media; Diagnosis, Differential; Female; Humans; Iodine; Ioh | 2016 |
Validation study for the hypothesis of internal mammary sentinel lymph node lymphatic drainage in breast cancer.
Topics: Adult; Aged; Axilla; Biopsy; Breast Neoplasms; Female; Fluorescent Dyes; Humans; Indocyanine Green; | 2016 |
Topics: Adult; Aged; Brachytherapy; Disease-Free Survival; Female; Humans; Iodine; Lymph Nodes; Lymphatic Me | 2017 |
Non-small cell lung cancer: Spectral computed tomography quantitative parameters for preoperative diagnosis of metastatic lymph nodes.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Contrast Media; Female; Humans; Iodine; Lung Neoplasms; | 2017 |
Functional imaging of lung cancer using dual energy CT: how does iodine related attenuation correlate with standardized uptake value of 18FDG-PET-CT?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Huma | 2012 |
Papillary thyroid microcarcinoma: clinicopathological characteristics and implications for treatment in 276 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; Female; Goiter; Greece; | 2012 |
Thyroid surgery in an area of iodine deficiency.
Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Adult; Catchment Area, Health; Female; Follow | 2005 |
Is patient's age a prognostic factor for follicular thyroid carcinoma in the TNM classification system?
Topics: Adenoma, Oxyphilic; Adolescent; Adult; Aged; Aged, 80 and over; Aging; Carcinoma, Papillary, Follicu | 2005 |
Aggressiveness of therapy and prognosis of patients with Hürthle cell papillary thyroid carcinoma.
Topics: Adenoma, Oxyphilic; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Pa | 2006 |
Distribution of Na+/I- symporter in thyroid cancers in an iodine-deficient population: an immunohistochemical study.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Biomarkers, Tumor; Carcinoma; Carcinoma, Papillary; Carcino | 2007 |
Plasma exchanges overcome persistent iodine overload to enable 131I ablation of differentiated thyroid carcinoma.
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Iodine; Iodine Radioisotopes; Lymphatic Metastasis; Male | 2008 |
Juvenile thyroid carcinoma with metastasis to the bilateral cervical lymph nodes--a case report.
Topics: Adenocarcinoma; Child; Humans; Iodine; Lymphatic Metastasis; Male; Neck Dissection; Radioisotopes; T | 1983 |
Thyrotrophin stimulation of adenylate cyclase and iodine uptake in human differentiated thyroid cancer.
Topics: Adenylyl Cyclases; Adolescent; Adult; Aged; Carcinoma; Carcinoma, Papillary; Humans; Iodine; Iodine | 1982 |
[The existence of thyroglobulin in metastatic lymph nodes of thyroid carcinoma and significance of measurement of blood Tg level after surgery].
Topics: Adult; Aged; Biomarkers, Tumor; Female; Humans; Iodine; Lymph Nodes; Lymphatic Metastasis; Male; Mid | 1995 |
Characterization of normal and cancerous lymph nodes on indirect computed tomography lymphographic studies after interstitial injection of iodinated nanoparticles.
Topics: Animals; Contrast Media; Dogs; Dose-Response Relationship, Drug; Female; Injections, Subcutaneous; I | 1996 |
Indirect computed tomography lymphography using iodinated nanoparticles to detect cancerous lymph nodes in a cutaneous melanoma model.
Topics: Animals; Contrast Media; Diatrizoate; Iodine; Lymph Nodes; Lymphatic Metastasis; Lymphography; Melan | 1996 |
Presternal extension of a malignant thyroid swelling.
Topics: Adult; Carcinoma, Papillary; Fascia; Female; Humans; Iodine; Lymph Nodes; Lymphatic Metastasis; Ster | 1999 |
Hyperthyroidism in a patient with TSH-producing pituitary adenoma coexisting with thyroid papillary adenocarcinoma.
Topics: Adenocarcinoma, Papillary; Adenoma; Adult; Biopsy, Needle; Female; Humans; Hyperthyroidism; Iodine; | 2000 |
[Differentiated thyroid carcinoma: prognostic factors].
Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma; Carcinoma, Papillary; Deficiency Diseases; Femal | 2001 |
Clinical features of differentiated thyroid carcinoma in children and adolescents from a sub-Himalayan iodine-deficient endemic zone.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Age Distribution; Bone Neoplasms; Carcinoma, Papillar | 2001 |
[Prevalence and aggressiveness of thyroid carcinoma with diameter less than one centimetre in iodine deficiency areas].
Topics: Adenocarcinoma, Follicular; Biopsy, Needle; Calcinosis; Carcinoma, Medullary; Carcinoma, Papillary; | 2002 |
Is the cervix normal? How do you arrive at that conclusion?
Topics: Biopsy; Carcinoma in Situ; Continuity of Patient Care; Female; Humans; Hysterectomy; Iodine; Lymphat | 1976 |
Endocrine and metabolic diseases. Treatment of thyroid diseases--II. Goitre.
Topics: Autoimmune Diseases; Goiter; Goiter, Endemic; Humans; Iodine; Lymphatic Metastasis; Lymphoma; Thyroi | 1976 |
[Initial symptoms of malignant thyroid tumors: the effect of age and sex in an iodine-deficient region. Experiences with 1116 patients].
Topics: Age Factors; Disease Reservoirs; Female; Germany, West; Humans; Iodine; Lymphatic Metastasis; Male; | 1989 |
Use of angio computed tomography to evaluate extent of endometrial carcinoma.
Topics: Contrast Media; Female; Humans; Iliac Artery; Iodine; Lymphatic Metastasis; Neoplasm Invasiveness; N | 1989 |
Experimental studies of the endolymphatic radiotherapy.
Topics: Animals; Bone Marrow; Dogs; Humans; Injections, Subcutaneous; Intestinal Mucosa; Iodine; Iodine Radi | 1974 |
Proceedings: Thyroid suppression.
Topics: Adenocarcinoma; Adult; Carcinoma; Carcinoma, Papillary; Diagnosis, Differential; Female; Humans; Iod | 1974 |
Immunohistochemical differentiation and localization analysis of sweat glands in the adult human axilla.
Topics: Adult; Aged; Apocrine Glands; Axilla; Biomarkers; Carrier Proteins; Dermis; Eccrine Glands; Female; | 2006 |